Douglas A. Bell
Impact in
- Cancer Research top 0.2%
- Carcinogens and Genotoxicity Assessment
- Pharmacology top 0.1%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Carcinogens and Genotoxicity Assessment 47
- Co-authors
- Jack A. TaylorXuting WangRuth M. LunnGary S. PittmanGeorge W. LucierJames L. MohlerAri HirvonenMary Ann Watson
- Journals
- Environmental Health Perspectives (14 papers)Carcinogenesis (10 papers)PLoS ONE (6 papers)International Journal of Cancer (6 papers)PLoS Genetics (6 papers)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Douglas A. Bell
249 papers receiving 16.5k citations
Hit Papers
Peers
Comparison fields: 5 of 181
- Cancer Research 3.9k
- Pharmacology 1.5k
- Molecular Biology 9.2k
- Health, Toxicology and Mutagenesis 1.7k
- Oncology 2.6k
Countries citing papers authored by Douglas A. Bell
This map shows the geographic impact of Douglas A. Bell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas A. Bell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas A. Bell more than expected).
Fields of papers citing papers by Douglas A. Bell
This network shows the impact of papers produced by Douglas A. Bell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas A. Bell. The network helps show where Douglas A. Bell may publish in the future.
Co-authors
The 25 scholars most cited alongside Douglas A. Bell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2022 | 12 | |
| 4 | 2021 | 24 | |
| 5 | 2020 | 1 | |
| 6 | 2019 | 15 | |
| 7 | 2015 | 43 | |
| 8 | 2014 | 96 | |
| 9 | 2006 | 1 | |
| 10 | 2005 | 3 | |
| 11 | Polychlorinated Biphenyls, Cytochrome P450 1A1 (CYP1A1) Polymorphisms, and Breast Cancer Risk Among African American Women and White Women in North Carolina: A Population-Based Case-Control Study | 2004 | 2 |
| 12 | 2004 | 53 | |
| 13 | Polymorphisms in the DNA repair gene XRCC1 and breast cancer. | 2001 | 131 |
| 14 | Polymorphisms In The DNA Repair Gene Xrcc1 And Breast Cancer | 2001 | 214 |
| 15 | 1999 | 67 | |
| 16 | 1997 | 36 | |
| 17 | 1996 | 242 | |
| 18 | CYP1A1 messenger RNA levels in placental tissue as a biomarker of environmental exposure. | 1995 | 46 |
| 19 | 1991 | 10 | |
| 20 | 1990 | 14 |
About Douglas A. Bell
Douglas A. Bell is a scholar working on Chemical Health and Safety, Cancer Research, Molecular Biology, Health, Toxicology and Mutagenesis and Developmental Biology, having authored 255 papers that have together received 17.0k indexed citations. Recurring topics across this work include Glutathione Transferases and Polymorphisms (55 papers), Carcinogens and Genotoxicity Assessment (47 papers), Epigenetics and DNA Methylation (44 papers), Genomics, phytochemicals, and oxidative stress (34 papers), Avian ecology and behavior (26 papers), RNA modifications and cancer (19 papers), Wildlife Ecology and Conservation (18 papers) and Cancer-related Molecular Pathways (16 papers). The work is most often cited by research in Cancer Research (3.9k citations), Pharmacology (1.5k citations), Molecular Biology (9.2k citations), Health, Toxicology and Mutagenesis (1.7k citations) and Oncology (2.6k citations). Douglas A. Bell has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Jack A. Taylor, Xuting Wang, Ruth M. Lunn, Gary S. Pittman, George W. Lucier, James L. Mohler, Ari Hirvonen, Mary Ann Watson, Claudia Thompson and Steven R. Kleeberger. Their work appears in journals such as Environmental Health Perspectives, Carcinogenesis, PLoS ONE, International Journal of Cancer and PLoS Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.